Oligodendrocyte

Oligodendrocytes are a type of neuroglia or glial cell found exclusively in the central nervous system (brain and spinal cord), primarily responsible for forming the myelin sheath that insulates neuronal axons, enabling rapid and efficient electrical signaling[1][5][7]. A single oligodendrocyte can myelinate segments of many axons, and these cells also provide critical metabolic and trophic support to neurons, regulate the extracellular environment, and play emerging roles in CNS immunomodulation and response to injury[1][3][5][9]. Oligodendrocyte precursor cells (OPCs) can differentiate to replenish oligodendrocyte populations, especially in response to demyelination[4][6][8]. Dysfunction or loss of oligodendrocytes is implicated in neurodegenerative diseases such as multiple sclerosis, where impaired myelination and axonal damage are key pathological features[3][4][8]. The cell itself is not a conventional drug target (i.e., not a receptor, enzyme, or transporter) but is an important focus for regenerative medicine and therapeutic strategies that aim to promote remyelination and neuroprotection in diseases of the CNS[4][2][8]. Additional notes: - "Oligodendrocyte" refers to a cell type, not a single molecular drug target; therefore, it does not have canonical molecular identifiers, abbreviations, or direct drug interactions/mechanisms typical of proteins or receptors[1][5][7]. - Drugs may indirectly target processes such as oligodendrocyte precursor differentiation and remyelination but do not directly bind or inhibit the oligodendrocyte as a singular molecular entity[4][2]. - Including "Oligodendrocyte" as a "receptor" or direct molecular target is incorrect for standard therapeutic target databases; it is a cell type.

Other names

oligodendrogliaOLOLsmyelinating glial cell